Epidemiology of severe anaphylaxis: Can we use population-based data to understand anaphylaxis?

Current Opinion in Allergy and Clinical Immunology

Volumn 16, Issue 5, 2016, Pages 441-450

  Turner, Paul J ^a,b   Campbell, Dianne E ^b,c  

^a IMPERIAL COLLEGE LONDON   (United Kingdom)

^b UNIVERSITY OF SYDNEY   (Australia)

^c CHILDREN S HOSPITAL AT WESTMEAD   (Australia)

Author keywords

Allergy; anaphylaxis; epidemiology

Indexed keywords

TRYPTASE; VENOM;

ANAPHYLAXIS; DATA ANALYSIS; DATA COLLECTION METHOD; DISEASE SEVERITY; DRUG HYPERSENSITIVITY; ENVENOMATION; FATALITY; FOOD ALLERGY; HIGH RISK POPULATION; HUMAN; IATROGENIC DISEASE; NONHUMAN; POPULATION RESEARCH; PRIORITY JOURNAL; REVIEW; ACUTE DISEASE; AGING; ANIMAL; AUSTRALIA; FACTUAL DATABASE; INCIDENCE; INFORMATION PROCESSING; POPULATION GROUP; STATISTICS; UNITED KINGDOM;

ACUTE DISEASE; AGING; ANAPHYLAXIS; ANIMALS; AUSTRALIA; DATABASES, FACTUAL; DATASETS AS TOPIC; HUMANS; INCIDENCE; POPULATION GROUPS; STATISTICS AS TOPIC; UNITED KINGDOM;

EID: 84982860546     PISSN: 15284050     EISSN: 14736322     Source Type: Journal    
DOI: 10.1097/ACI.0000000000000305     Document Type: Review

References (63)

1. Simons FE, Ardusso LR, Bilò MB, et al. International consensus on (ICON) anaphylaxis. World Allergy Organ J 2014; 7:9.
2. Doeing DC, Borowicz JL, Crockett ET. Gender dimorphism in differential peripheral blood leukocyte counts in mice using cardiac, tail, foot, and saphenous vein puncture methods. BMC Clin Pathol 2003; 3:3.
3. Mestas J, Hughes CC. Of mice and not men: differences between mouse and human immunology. J Immunol 2004; 172:2731-2738.
4. Finkelman FD, Rothenberg ME, Brandt EB, et al. Molecular mechanisms of anaphylaxis: lessons from studies with murine models. J Allergy Clin Immunol 2005; 115:449-457.
5. Finkelman FD, Khodoun MV, Strait R. Human IgE-independent systemic anaphylaxis. J Allergy Clin Immunol 2016; 137:1674-1680.
6. Smit JJ, Willemsen K, Hassing I, et al. Contribution of classic and alternative effector pathways in peanut-induced anaphylactic responses. PLoS One 2011; 6:e28917.
7. Allen KJ, Remington BC, Baumert JL, et al. Allergen reference doses for precautionary labeling (VITAL 2.0): clinical implications. J Allergy Clin Immunol 2014; 133:156-164.
8. Bergman RK, Munoz JJ. Increased histamine sensitivity in mice after administration of endotoxins. Infect Immun 1977; 15:72-77.
9. Kaliner M, Shelhamer JH, Ottesen EA. Effects of infused histamine: correlation of plasma histamine levels and symptoms. J Allergy Clin Immunol 1982; 69:283-289.
10. Wang M, Han J, Domenico J, et al. Combined blockade of the histamine H1 and H4 receptor suppresses peanut-induced intestinal anaphylaxis by regulating dendritic cell function. Allergy 2016. doi: 10.1111/all.12904.
11. Sheikh A, Ten Broek V, Brown SG, Simons FE. H1-antihistamines for the treatment of anaphylaxis: Cochrane systematic review. Allergy 2007; 62:830-837.
12. Liu C, Wilson SJ, Kuei C, Lovenberg TW. Comparison of human, mouse, rat, and guinea pig histamine H4 receptors reveals substantial pharmacological species variation. J Pharmacol Exp Ther 2001; 299:121-130.
13. Tsujimura Y, Obata K, Mukai K, et al. Basophils play a pivotal role in immunoglobulin-G-mediated but not immunoglobulin-E-mediated systemic anaphylaxis. Immunity 2008; 28:581-589.
14. Betz SJ, Lotner GZ, Henson PM. Generation and release of platelet-activating factor (PAF) from enriched preparations of rabbit basophils; failure of human basophils to release PAF. J Immunol 1980; 125:2749-2755.
15. Panesar SS, Javad S, de Silva D, et al., on behalf of the EAACI Food Allergy and Anaphylaxis Group. The epidemiology of anaphylaxis in Europe: a systematic review. Allergy 2013; 68:1353-1361.
16. Simons FER, Ardusso LRF, Bilò MB, et al. World Allergy Organization guidelines for the assessment and management of anaphylaxis. World Allergy Organ J 2011; 4:13-37.
17. Lieberman P, Nicklas RA, Oppenheimer J, et al. The diagnosis and management of anaphylaxis practice parameter: 2010 update. J Allergy Clin Immunol 2010; 126:477-480.
18. Brown SG, Mullins RJ, Gold MS. Anaphylaxis: diagnosis and management. Med J Aust 2006; 185:283-289.
19. Sampson HA, Muñ oz-Furlong A, Campbell RL, et al. Second symposium on the definition and management of anaphylaxis: summary report: Second National Institute of Allergy and Infectious Disease/Food Allergy and Anaphylaxis Network symposium. J Allergy Clin Immunol 2006; 117:391-397.
20. Pumphrey RSH. An epidemiological approach to reducing the risk of fatal anaphylaxis. In anaphylaxis and hypersensitivity reactions. In: Castells MC, editor. Anaphylaxis and hypersensitivity reactions. Asthma and COPD. New York, Dordrecht, Heidelberg, London: Springer Science Ltd, Humana Press; 2011. pp. 13-31.
21. Noimark L, Wales J, Du Toit G, et al. The use of adrenaline autoinjectors by children and teenagers. Clin Exp Allergy 2012; 42:284-292.
22. Turner PJ, Baumert JL, Beyer K, et al. Can we identify patients at risk of lifethreatening allergic reactions to food? Allergy 2016. doi: 10.1111/all.12924.
23. Umasunthar T, Leonardi-Bee J, Turner PJ, et al. Incidence of food anaphylaxis in people with food allergy: a systematic review and meta-analysis. Clin Exp Allergy 2015; 45:1621-1636.
24. Mukherjee M, Wyatt JC, Simpson CR, Sheikh A. Usage of allergy codes in primary care electronic health records: a national evaluation in Scotland. Allergy 2016. doi: 10.1111/all.12928.
25. Turner PJ, Gowland MH, Sharma V, et al. Increase in anaphylaxis-related hospitalizations but no increase in fatalities: an analysis of United Kingdom national anaphylaxis data. J Allergy Clin Immunol 2015; 135:956-963.
26. Ma L, Danoff TM, Borish L. Case fatality and population mortality associated with anaphylaxis in the United States. J Allergy Clin Immunol 2014; 133:1075-1083.
27. Jerschow E, Lin RY, Scaperotti MM, McGinn AP. Fatal anaphylaxis in the United States, 1999-2010: temporal patterns and demographic associations. J Allergy Clin Immunol 2014; 134:1318-1328.
28. Mullins RJ, Wainstein BK, Barnes EH, et al. Increases in anaphylaxis fatalities in Australia 1997 to 2013. Clin Exp Allergy 2016. doi: 10.1111/cea.12748.
29. Worm M, Moneret-Vautrin A, Scherer K, et al. First European data from the network of severe allergic reactions (NORA). Allergy 2014; 69:1397-1404.
30. Grabenhenrich LB, Dö lle S, Moneret-Vautrin A, et al. Anaphylaxis in children and adolescents: the European Anaphylaxis Registry. J Allergy Clin Immunol 2016; 137:1128-1137.
31. Canadian Institute for Health Information. Anaphylaxis and Allergy in the Emergency Department, 2015. https://www.cihi.ca/sites/default/files/docu ment/anaphylaxis-infosheet-enweb.pdf. [Accessed 5 June 2016]
32. Mullins RJ, Dear KB, Tang ML. Time trends in Australian hospital anaphylaxis admissions in 1998-1999 to 2011-2012. J Allergy Clin Immunol 2015; 136:367-375.
33. Xu YS, Kastner M, Harada L, et al. Anaphylaxis-related deaths in Ontario: a retrospective review of cases from 1986 to 2011. Allergy Asthma Clin Immunol 2014; 10:38.
34. Umasunthar T, Leonardi-Bee J, Hodes M, et al. Incidence of fatal food anaphylaxis in people with food allergy: a systematic review and metaanalysis. Clin Exp Allergy 2013; 43:1333-1341.
35. Prescott SL, Pawankar R, Allen KJ, et al. A global survey of changing patterns of food allergy burden in children. World Allergy Organ J 2013; 6:21.
36. Akinbami LJ, Moorman JE, Bailey C, et al. Trends in asthma prevalence, healthcare use, and mortality in the United States, 2001-2010. NCHS Data Brief 2012; 94:1-8.
37. Buka RJ, Crossman RJ, Melchior CL, et al. Anaphylaxis and ethnicity: higher incidence in British South Asians. Allergy 2015; 70:1580-1587.
38. Koplin JJ, Peters RL, Ponsonby AL, et al. Increased risk of peanut allergy in infants of Asian-born parents compared to those of Australian-born parents. Allergy 2014; 69:1639-1647.
39. Clark AT, Ewan PW. Good prognosis, clinical features, and circumstances of peanut and tree nut reactions in children treated by a specialist allergy center. J Allergy Clin Immunol 2008; 122:286-289.
40. Rudders SA, Banerji A, Vassallo MF, et al. Trends in pediatric emergency department visits for food-induced anaphylaxis. J Allergy Clin Immunol 2010; 126:385-388.
41. Asai Y, Yanishevsky Y, Clarke A, et al. Rate, triggers, severity and management of anaphylaxis in adults treated in a Canadian emergency department. Int Arch Allergy Immunol 2014; 164:246-252.
42. Who, what, why: where are all the wasps? http://www.bbc.co.uk/news/magazine-23356578. [Accessed 28 May 2016]
43. Worm M, Eckermann O, Dö lle S, et al. Triggers and treatment of anaphylaxis: an analysis of 4000 cases from Germany, Austria and Switzerland. Dtsch Arztebl Int 2014; 111:367-375.
44. Department of Human Services AG. Pharmaceutical Benefits Schedule Item Reports. http://medicarestatistics.humanservices.gov.au/statistics/pbs-item. jsp. [Accessed 5 June 2016]
45. Boyle RJ, ElremeliM, Hockenhull J, et al. Venom immunotherapy for preventing allergic reactions to insect stings. Cochrane Database Syst Rev 2012; 10:CD008838.
46. Paolocci G, Folletti I, Torén K, et al. Hymenoptera venom allergy: work disability and occupational impact of venom immunotherapy. BMJ Open 2014; 4:e005593.
47. Clark S, Wei W, Rudders SA, Camargo CA Jr. Risk factors for severe anaphylaxis in patients receiving anaphylaxis treatment in US emergency departments and hospitals. J Allergy Clin Immunol 2014; 134:1125-1130.
48. Brown SG,Stone SF, Fatovich DM, et al.Anaphylaxis: clinical patterns, mediator release, and severity. J Allergy Clin Immunol 2013; 132:1141-1149.
49. Ye Y-M, Kim MK, Kang H-R, et al. Predictors of the severity and serious outcomes of anaphylaxis in Korean adults: a multicenter retrospective case study. Allergy Asthma Immunol Res 2015; 7:22-29.
50. Jares EJ, Baena-Cagnani CE, Sánchez-Borges M, et al. Drug-induced anaphylaxis in Latin American countries. J Allergy Clin Immunol Pract 2015; 3:780-788.
51. Nassiri M, Babina M, Dö lle S, et al. Ramipril and metoprolol intake aggravate human and murine anaphylaxis: evidence for direct mast cell priming. J Allergy Clin Immunol 2015; 135:491-499.
52. Palmiere C, Reggiani Bonetti L. Risk factors in fatal cases of anaphylaxis due to contrast media: a forensic evaluation. Int Arch Allergy Immunol 2014; 164:280-288.
53. McLean-Tooke A, Goulding M, Bundell C, et al. Postmortem serum tryptase levels in anaphylactic and nonanaphylactic deaths. J Clin Pathol 2014; 67:134-138.
54. Ruë ff F, Przybilla B, Biló MB, et al. Predictors of severe systemic anaphylactic reactions in patients with Hymenoptera venom allergy: importance of baseline serum tryptase: a study of the European Academy of Allergology and Clinical Immunology Interest Group on Insect Venom Hypersensitivity. J Allergy Clin Immunol 2009; 124:1047-1054.
55. Borer-Reinhold M, Haeberli G, Bitzenhofer M, et al. An increase in serum tryptase even below 11.4 ng/mL may indicate a mast cell-mediated hypersensitivity reaction: a prospective study in Hymenoptera venom allergic patients. Clin Exp Allergy 2011; 41:1777-1783.
56. Fellinger C, Hemmer W, Wö hrl S, et al. Clinical characteristics and risk profile of patients with elevated baseline serum tryptase. Allergol Immunopathol (Madr) 2014; 42:544-552.
57. Sahiner UM, Yavuz ST, Buyuktiryaki B, et al. Serum basal tryptase may be a good marker for predicting the risk of anaphylaxis in children with food allergy. Allergy 2014; 69:265-268.
58. Worm M, Edenharter G, Ruëff F, et al. Symptom profile and risk factors of anaphylaxis in Central Europe. Allergy 2012; 67:691-698.
59. de Silva IL, Mehr SS, Tey D, Tang ML. Paediatric anaphylaxis: a 5 year retrospective review. Allergy 2008; 63:1071-1076.
60. O'Leary FM, Hokin B, Enright K, Campbell DE. Treatment of a simulated child with anaphylaxis: an in situ two-arm study. J Paediatr Child Health 2013; 49:541-547.
61. Dirks CG, Pedersen MH, Platzer MH, et al. Does absorption across the buccal mucosa explain early onset of food-induced allergic systemic reactions? J Allergy Clin Immunol 2005; 115:1321-1323.
62. Lin RY, Schwartz LB, Curry A, et al. Histamine and tryptase levels in patients with acute allergic reactions: an emergency department-based study. J Allergy Clin Immunol 2000; 106:65-71.
63. Sala-Cunill A, Cardona V, Labrador-Horrillo M, et al. Usefulness and limitations of sequential serum tryptase for the diagnosis of anaphylaxis in 102 patients. Int Arch Allergy Immunol 2013; 160:192-199.